Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 443421 - 443440 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (L01XC02) rituximab | Mabthera® | 200, 100 mg , Injektionsflaska, 2 x 100 mg (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | ParanovaLäkemedelAB |
| Sweden | (L01XC02) rituximab | Mabthera® | 200, 100 mg , Injektionsflaska, 2 x 100 mg | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | RocheAB |
| Sweden | (L01XC02) rituximab | Mabthera® | 500, 500 mg , Injektionsflaska, 500 mg | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | RocheAB |
| Sweden | (L01XC02) rituximab | Mabthera® | 500, 500 mg , Injektionsflaska, 500 mg (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | ParanovaLäkemedelAB |
| Sweden | (L01XC02) rituximab | Mabthera® | 500, 500 mg , Injektionsflaska, 500 mg (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | MedartuumAB |
| Sweden | (L01XC03) trastuzumab | Herceptin® | 1, 150 mg , Injektionsflaska, 1 x 150 mg (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | ParanovaLäkemedelAB |
| Sweden | (L01XC03) trastuzumab | Herceptin® | 1, 150 mg , Injektionsflaska, 1 x 150 mg (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | MedartuumAB |
| Sweden | (L01XC03) trastuzumab | Herceptin® | 1, 150 mg , Injektionsflaska, 1 x 150 mg | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheAB |
| Sweden | (L01XC03) trastuzumab | Herceptin® | 1, 150 mg , Injektionsflaska, 1 x 150 mg (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AbacusMedicineA/S |
| Sweden | (L01XC03) trastuzumab | Herceptin® | 1, 150 mg , Injektionsflaska, 1 x 150 mg (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | OrifarmAB |
| Sweden | (L01XC12) brentuximab vedotin | ADCETRIS | 1, 50 mg , Injektionsflaska, 1 st. | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Hodgkin Disease | TakedaPharmaAB |
| Sweden | (L01XD03) methyl aminolevulinate | Metvix | 2, 160 mg/g , Tub, 2 g | Retail price without vat |
$0-0 |
$0-0 |
n/a | MedartuumAB |
| Sweden | (L01XD03) methyl aminolevulinate | Metvix® | 2, 160 mg/g , Tub, 2 g | Retail price without vat |
$0-0 |
$0-0 |
n/a | GaldermaNordicAB |
| Sweden | (L01XD04) aminolevulinic acid | Ameluz | 2, 78 mg/g , Tub, 2 g (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Keratosis, Actinic; Carcinoma, Basal Cell | MedartuumAB |
| Sweden | (L01XD04) aminolevulinic acid | Ameluz | 2, 78 mg/g , Tub, 2 g (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Keratosis, Actinic; Carcinoma, Basal Cell | ParanovaLäkemedelAB |
| Sweden | (L01XD04) aminolevulinic acid | Ameluz | 2, 78 mg/g , Tub, 2 g | Retail price without vat |
$0-0 |
$0-0 |
Keratosis, Actinic; Carcinoma, Basal Cell | GalenicaAB |
| Sweden | (L01XE27) ibrutinib | IMBRUVICA | 120, 140 mg , Burk, 120 kapslar | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
| Sweden | (L01XE27) ibrutinib | IMBRUVICA | 90, 140 mg , Burk, 90 kapslar (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | OrifarmAB |
| Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 140 mg , Blister, 28 x 1 tabletter (endos) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
| Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 140 mg , Blister, 28 x 1 tabletter (endos) (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | OrifarmAB |
Pages
